No Data
No Data
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Altamira Therapeutics Announces Transition From NASDAQ to OTC Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Altamira Therapeutics Receives Letter From Nasdaq Qualifications Department That It Is No Longer In Compliance
Express News | Altamira Therapeutics: Got on Sept 30, a Letter From Nasdaq That It No Longer Complied With Rule 5550(a)(2) of Nasdaq's Listing Rules
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
No Data